News
The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...
The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review ...
In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...
About mRESVIA® (Respiratory Syncytial Virus Vaccine) ... (LNPs) as the Moderna COVID-19 vaccines. About Moderna. Moderna is a leader in the creation of the field of mRNA medicine.
FDA clears Moderna’s RSV vaccine for use in people aged 18 to 59. The extension of the shot’s approval is a welcome win for company after recent setbacks. Manage alerts for this article; ...
Moderna's mRNA flu vaccine showed 26.6% better efficacy than a standard flu shot in adults 50 and older during a global Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results